Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Transplant Recipient Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT00271830
What this trial is testing

Sexual Function in Male Renal Transplant Patients

Who this might be right for
Renal Transplant Recipients
Montefiore Medical Center 110
Large-scale testing (Phase 3)Study completedNCT00239070
What this trial is testing

Extension Study on the Safety and Efficacy of Enteric-coated Mycophenolate Sodium in Kidney Transplant Recipients

Who this might be right for
Renal Transplantation
Novartis 69
Post-approval studies (Phase 4)Looking for participantsNCT07143773
What this trial is testing

SGLT2i Safety and Efficacy on Kidney Allograft Function in Non-diabetic Kidney Transplant Recipients

Who this might be right for
Kidney Transplantation RecipientsSodium-Glucose Transporter 2 InhibitorsNon-Diabetic Patients+2 more
Odense University Hospital 88
Large-scale testing (Phase 3)Ended earlyNCT04258423
What this trial is testing

Everolimus Plus Mycophenolic Acid for Kidney Preservation in Liver Transplant Recipients With Impaired Kidney Function

Who this might be right for
Kidney Failure
Indiana University 4
Large-scale testing (Phase 3)Study completedNCT00149903
What this trial is testing

Study of Enteric-coated Mycophenolate Sodium Versus Mycophenolate Mofetil in Adult de Novo Renal Transplant Patients

Who this might be right for
Renal Transplant
Novartis Pharmaceuticals 300
Post-approval studies (Phase 4)WithdrawnNCT04614142
What this trial is testing

Single Patient Protocol for Donor HCV-positive to Recipient HCV-negative Kidney Transplant in a Patient at Risk for Loss of Dialysis Access

Who this might be right for
End Stage Renal DiseaseChronic Hepatitis c
Massachusetts General Hospital
Not applicableUnknownNCT06950931
What this trial is testing

Posttranslationally Modified Fetuin-A in Urine as a Marker for Renal Dysfunction (Patients With Chronic Kidney Disease - With or Without Kidney Transplantation).

Who this might be right for
Transplant Recipient (Kidney)Primary Kidney Transplantation
University Hospital, Martin 86
Large-scale testing (Phase 3)Study completedNCT00097968
What this trial is testing

Safety/Efficacy of Everolimus and Neoral® in Adult Cardiac Transplant Patients With Established Allograft Vasculopathy

Who this might be right for
Graft Rejection
Novartis Pharmaceuticals
Not applicableUnknownNCT04932876
What this trial is testing

The Response of the Immune System of Patients With End Stage Kidney Disease on Dialysis and Kidney Transplant Recipients Vaccinated for COVID-19

Who this might be right for
End Stage Kidney DiseaseKidney TransplantionCovid19+1 more
University of Ioannina 100
Testing effectiveness (Phase 2)Study completedNCT01064791
What this trial is testing

Efficacy, Safety, Tolerability, and Pharmacokinetics of Sotrastaurin Combined With Tacrolimus vs. a Mycophenolic Acid-tacrolimus Regimen in Renal Transplant Patients

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 298
Not applicableStudy completedNCT01709097
What this trial is testing

Compliance/Adherence After Kidney Transplant, With or With Out Med-O-Wheel™.

Who this might be right for
Medication AdherenceComplianceMedication Nonadherence+2 more
Karolinska University Hospital 80
Large-scale testing (Phase 3)Ended earlyNCT01450878
What this trial is testing

Renal Graft Function After Treatment With Erythropoietin (EPO)

Who this might be right for
Ischemia
University Hospital, Limoges 6
Not applicableStudy completedNCT01280617
What this trial is testing

Low Dose Thymoglobin in Renal Transplant Patients

Who this might be right for
Acute Renal Failure
Lahey Clinic 44
Not applicableUnknownNCT02042963
What this trial is testing

KoreaN Cohort Study for Outcome in Patients With Kidney Transplantation (KNOW-KT)

Who this might be right for
Kidney Transplant RecipientsComplications After Kidney Transplant
Seoul National University Hospital 1,000
Large-scale testing (Phase 3)Study completedNCT04169698
What this trial is testing

Alendronate Versus Denosumab in Kidney Transplant Patients

Who this might be right for
Osteoporosis, OsteopeniaRenal Transplant Recipient
Ain Shams University 90
Post-approval studies (Phase 4)Study completedNCT01446445
What this trial is testing

Individualization of Ganciclovir and Valganciclovir Doses Using Bayesian Prediction in Renal Transplant Patients.

Who this might be right for
Infection in Solid Organ Transplant Recipients
Nuria Lloberas 60
Large-scale testing (Phase 3)Not Yet RecruitingNCT07828223
What this trial is testing

Cardiac Improvement by Eplerenone Among Patients Under Cyclosporine or Tacrolimus for Kidney Transplantation.

Who this might be right for
Kidney Transplantation
Central Hospital, Nancy, France 132
Post-approval studies (Phase 4)Study completedNCT01889758
What this trial is testing

Pharmacokinetic Studies of Tacrolimus in Transplant Patients

Who this might be right for
Kidney Transplant RecipientsLiver Transplant Recipients
University of Cincinnati 78
Post-approval studies (Phase 4)Study completedNCT01265615
What this trial is testing

Paricalcitol Versus Calcitriol for the Management of Renocardiac Syndrome in Renal Transplant Patients

Who this might be right for
Cardiorenal SyndromeChronic Allograft Nephropathy
Ural State Medical University 109
Testing effectiveness (Phase 2)Active Not RecruitingNCT07092865
What this trial is testing

A Study Evaluating Persistence of the Immune Response of the Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine and the Safety and Immune Response Following Revaccination in Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 168
Next Page